A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 186 patients (estimated)
- Sponsors
- Orca Biosystems, Inc.
- Tags
- Allogeneic Stem Cell Transplant
- Trial Type
- Supportive
- Last Update
- 1 week ago
- SparkCures ID
- 1669
- NCT Identifier
- NCT03802695
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.